FDA warns of muscle damage from high doses of Zocor
The FDA recently announced that it will require the makers of Simvastatin (generic) and Zocor to strengthen their warnings. It seems that the FDA has been studying the effects of this drug for 7 years. The FDA study revealed that some of the patients in the study taking the highest dosage (80 mgs) of Simvasatin or Zocor sustained muscle damage.
Critics question why the FDA waited so long to issue the warning about the increased risk of muscle damage associated with Zocor and it's generic equivalent, Simvastatin.
The kind of muscle damage associated with Simvastatin and Zocor can lead to a condition known as rhabdomyalisis which can shut down the kidneys and result in death.
It is estimated that 2.1 million Americans are taking the 80mg dose of Simvastatin or Zocor. If you or a loved one are taking either of these drugs, particularly at higher doses, you would be well advised to call your doctor as soon as possible and discuss your options.
To learn more about Zocor lawsuit, visit vanweylaw.com. If you are interested in learning more about how dangerous drugs like Zocor stay on the market, download your free copy of attorney Kay L. Van Wey's recent book on the subject, "Prescription Drug Safety. Seven Secrets the Pharmaceutical Industry Does Not Want You To Know".
